N01199 1077 — Burlington, Massachusetts

N01199 1077 is a clinical research site located in Burlington, Massachusetts, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

N01199 1077 has participated in 1 clinical trials.

Therapeutic areas: Epilepsy.

Sponsors: UCB PHARMA Inc. (US).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Burlington

Browse all research sites in Massachusetts · View every site in Burlington

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for N01199 1077?

N01199 1077 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has N01199 1077 conducted?

N01199 1077 has 1 clinical trials on record. Their work covers Epilepsy.

Is N01199 1077 accredited by Crixeo Clinical Trials?

N01199 1077 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about N01199 1077?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.